One study [52] examined the reversal of hypertension and elements of endothelial dysfunction on PAR2 and blood vessel function after treatment of animals with telmisartan, an angiotensin-II type 1 receptor antagonist. This evidence concerns the gene F2RL1 and hypertensive disorder.